Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1006 of 1,261
  1. US 7696159

    Treatment for basal cell carcinoma

    Graceway Pharmaceuticals. LLC · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  2. US 7696338

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  3. US 7696227

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  4. US 7696246

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  5. US 7695627

    Tangential flow filtration devices and methods for leukocyte enrichment

    Northwest Biotherapeutics, Inc. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  6. US 7695737

    Spherical composite particles and cosmetics with the particles blended therein

    JGC Catalysts and Chemicals Ltd. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  7. US 7696306

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  8. US 7691386

    Chimeric papillomavirus-like particles

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  9. US 7691878

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  10. US 7691832

    Methods of treatment of inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  11. US 7692009

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  12. US 7691872

    Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds

    New Century Pharmaceuticals, Inc. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  13. US 7691965

    Helical synthetic peptides that stimulate cellular cholesterol efflux

    The Regents of the University of California · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  14. US 7691862

    Method and composition for treating periodontal disease

    Regena Therapeutics LC · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  15. US 7691824

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  16. US 7691853

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  17. US 7691607

    Expression system of NELL peptide

    The Regents of the University of California · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  18. US 7691582

    Methods of secretory vimentin detection and modulation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  19. US 7691579

    Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  20. US 7691380

    Combined methods for tumor coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  21. US 7691567

    Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin

    The Board of Regents of the University of Texas System · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  22. US 7692010

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  23. US 7692008

    Reference standard for characterization of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted
  24. US 7691895

    Thrombopoietin activity modulating compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.